Arbuckle Stuart A's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 24, 2023
- Accession no.
- 0001209191-23-012672
- Filed
- Feb 24, 2023
- Trade date
- Feb 22, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $706.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arbuckle Stuart ACIK 0001557290 | Officer (EVP, COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 22, 2023 | Common Stock | SSaleDisposed | −129 | $291.84F2,F3 | −$37,647.36 | 68,576 | Direct | |
| Feb 22, 2023 | Common Stock | SSaleDisposed | −300 | $292.86F2,F4 | −$87,858 | 68,276 | Direct | |
| Feb 22, 2023 | Common Stock | SSaleDisposed | −1,378 | $294.29F2,F5 | −$405,531.62 | 66,898 | Direct | |
| Feb 22, 2023 | Common Stock | SSaleDisposed | −394 | $295.38F2,F6 | −$116,379.72 | 66,504 | Direct | |
| Feb 22, 2023 | Common Stock | SSaleDisposed | −200 | $296.31F2,F7 | −$59,262 | 66,304 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 5 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $291.84 (range $291.17 to $292.03).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $292.86 (range $292.44 to $293.37).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $294.29 (range $293.83 to $294.82).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $295.38 (range $294.83 to $295.72).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $296.31 (range $296.20 to $296.41).
Referenced by the price of 1 transaction in Table I.